<DOC>
	<DOC>NCT02036229</DOC>
	<brief_summary>The purpose of this study is to determine whether 0.5% ivermectin cream is effective in the treatment of demodicidosis (including papulopustular rosacea)</brief_summary>
	<brief_title>Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>subjects with clinical and laboratory diagnosis of demodicidosis with symmetrical facial eruption who are willing to comply with study requirements known hypersensitivity to ivermectin. pregnancy immunodeficiency such as HIV or immunosuppressive therapy concomitant use of systemic antibiotics or steroids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>demodex</keyword>
	<keyword>demodicidosis</keyword>
	<keyword>rosacea</keyword>
	<keyword>ivermectin</keyword>
</DOC>